Lombard Odier Asset Management Switzerland SA Makes New Investment in Axon Enterprise, Inc $AXON

Posted by Francis Steltz on Jul 29th, 2026

Lombard Odier Asset Management Switzerland SA purchased a new position in shares of Axon Enterprise, Inc (NASDAQ:AXON – Free Report) in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund purchased 1,245 shares of the biotechnology company’s stock, valued at approximately $529,000.

Several other large investors have also added to or reduced their stakes in the company. Creative Financial Designs Inc. ADV acquired a new position in shares of Axon Enterprise in the fourth quarter valued at about $28,000. Sound Income Strategies LLC raised its stake in shares of Axon Enterprise by 550.0% in the fourth quarter. Sound Income Strategies LLC now owns 52 shares of the biotechnology company’s stock worth $30,000 after purchasing an additional 44 shares during the last quarter. Camelot Portfolios LLC acquired a new stake in shares of Axon Enterprise during the fourth quarter worth about $30,000. AlphaCentric Advisors LLC acquired a new stake in shares of Axon Enterprise during the fourth quarter worth about $34,000. Finally, Lodestone Wealth Management LLC purchased a new stake in Axon Enterprise in the fourth quarter valued at approximately $35,000. Hedge funds and other institutional investors own 79.08% of the company’s stock.

Axon Enterprise Price Performance

Shares of NASDAQ AXON opened at $547.65 on Wednesday. The company has a debt-to-equity ratio of 0.49, a current ratio of 2.27 and a quick ratio of 1.93. The stock has a market capitalization of $44.14 billion, a price-to-earnings ratio of 219.94, a PEG ratio of 10.72 and a beta of 1.38. The firm’s 50 day simple moving average is $488.89 and its 200-day simple moving average is $477.58. Axon Enterprise, Inc has a 12 month low of $339.01 and a 12 month high of $885.91.

Axon Enterprise (NASDAQ:AXON – Get Free Report) last posted its earnings results on Wednesday, May 6th. The biotechnology company reported $1.61 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.60 by $0.01. Axon Enterprise had a net margin of 6.90% and a return on equity of 3.78%. The firm had revenue of $807.35 million during the quarter, compared to analysts’ expectations of $778.90 million. During the same period in the previous year, the business posted $1.47 EPS. The business’s revenue was up 33.7% compared to the same quarter last year. Analysts expect that Axon Enterprise, Inc will post 1.63 EPS for the current year.

Insider Activity at Axon Enterprise

In other news, President Joshua Isner sold 13,000 shares of the stock in a transaction dated Friday, June 5th. The shares were sold at an average price of $488.45, for a total transaction of $6,349,850.00. Following the sale, the president directly owned 169,125 shares of the company’s stock, valued at $82,609,106.25. This represents a 7.14% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Caitlin Elizabeth Kalinowski sold 564 shares of the stock in a transaction dated Monday, June 1st. The stock was sold at an average price of $478.97, for a total transaction of $270,139.08. Following the sale, the director directly owned 3,632 shares in the company, valued at approximately $1,739,619.04. The trade was a 13.44% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold 58,989 shares of company stock valued at $30,527,983 in the last quarter. 4.20% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

Several equities analysts recently weighed in on AXON shares. Weiss Ratings upgraded shares of Axon Enterprise from a “sell (d+)” rating to a “hold (c-)” rating in a report on Friday, May 8th. Morgan Stanley set a $600.00 price objective on shares of Axon Enterprise in a research note on Thursday, May 7th. Zacks Research downgraded shares of Axon Enterprise from a “strong-buy” rating to a “hold” rating in a report on Friday, July 10th. Barclays cut their price objective on shares of Axon Enterprise from $682.00 to $523.00 and set an “overweight” rating on the stock in a research note on Friday, May 8th. Finally, TD Cowen reissued a “buy” rating on shares of Axon Enterprise in a report on Wednesday, July 22nd. Fifteen equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $725.25.

View Our Latest Research Report on AXON

About Axon Enterprise

(Free Report)

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.

Institutional Ownership by Quarter for Axon Enterprise (NASDAQ:AXON)

Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.